ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You
should read the following discussion in conjunction with our consolidated financial statements and related notes and information included
elsewhere in this annual report on Form 10-K. You should review the “Risk Factors” section of this annual report for a discussion
of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking
statements contained in the following discussion and analysis. Some of the information contained in this discussion and analysis and
set forth elsewhere in this annual report on Form 10-K includes forward-looking statements that involve risks and uncertainties.
Unless
context denotes otherwise, the terms “Company,” “FGF,” “we,” “us,” and “our,”
refer to FG Financial Group, Inc., and its subsidiaries.
Overview
FG
Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant
banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating
capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking
activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also
provides asset management services. From our inception in October 2012 through December 2019, we operated as an insurance holding company,
writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three
former insurance subsidiaries, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.
As
of December 31, 2022, Fundamental Global GP, LLC (“FG”), a private partnership focused on long-term strategic holdings, and
its affiliated entity collectively beneficially owned approximately 60.0% of our common stock. D. Kyle Cerminara, Chairman of our Board
of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.
Sale
of Insurance Business
On
December 2, 2019, we completed the sale (“Asset Sale”) of our insurance subsidiaries to FedNat Holding Company for a combination
of cash and FedNat common stock. The Company sold its remaining FedNat common stock shares held in October 2022.
Critical
Accounting Estimates
Critical
accounting estimates are those estimates made in accordance with generally accepted accounting principles that involve a significant
level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results
of operations. Actual results may differ materially from these estimates. The business and economic uncertainty resulting from the coronavirus
(COVID-19) pandemic has made such estimates and assumptions difficult to calculate. Set forth below is qualitative and quantitative information
necessary to understand the estimation uncertainty and the impact the critical accounting estimate has had or is reasonably likely to
have on financial condition or results of operations, to the extent the information is material and reasonably available.
Other
Investments
Other
investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. As discussed
further in Note 4, certain investments held by our equity method investees are valued using Monte-Carlo
simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected
volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments
based on the historical performance of various broad market indices blended with various peer companies which they consider as having
similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities
such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing SPAC equity.
Valuation
of Net Deferred Income Taxes
The
provision for income taxes is calculated based on the expected tax treatment of transactions recorded in the Company’s consolidated
financial statements. In determining its provision for income taxes, the Company interprets tax legislation in a variety of jurisdictions
and makes assumptions about the expected timing of the reversal of deferred income tax assets and liabilities and the valuation of net
deferred income taxes.
The
ultimate realization of the deferred income tax asset balance is dependent upon the generation of future taxable income during the periods
in which the Company’s temporary differences reverse and become deductible. A valuation allowance is established when it is more
likely than not that all or a portion of the deferred income tax asset balance will not be realized. In determining whether a valuation
allowance is needed, management considers all available positive and negative evidence affecting specific deferred income tax asset balances,
including the Company’s past and anticipated future performance, the reversal of deferred income tax liabilities, and the availability
of tax planning strategies. To the extent a valuation allowance is established in a period, an expense must be recorded within the income
tax provision in the consolidated statements of income and comprehensive income.
Premium
Revenue Recognition
The
Company participates in reinsurance quota-share contracts and estimates the ultimate premiums for the contract period. These estimates
are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the
underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly
and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums
relating to the risks underwritten during the lag period.
Premium
estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected ultimate
premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these
estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not
unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance
balances receivable” in the Company’s consolidated balance sheets represent estimated premiums written, net of commissions,
brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts.
Premiums
written are generally recognized as earned over the contract period in proportion to the risk covered. Additional premiums due on a contract
that has no remaining coverage period are earned in full when written. Unearned premiums represent the unexpired portion of reinsurance
provided.
Deferred
Policy Acquisition Costs
Policy
acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal reinsurance business,
and consist principally of commissions, taxes, and brokerage expenses. If the sum of a contract’s expected losses and loss expenses
and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined
to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the
premium deficiency exceeds deferred acquisition costs, then a liability is accrued for the excess deficiency. There were no premium deficiency
adjustments recognized during the periods presented herein.
Loss
and Loss Adjustment Expense Reserves
Loss
and loss adjustment expense reserve estimates are based on estimates derived from reports received from ceding companies. These estimates
are periodically reviewed by the Company’s management and adjusted as necessary. Since reserves are estimates, the final settlement
of losses may vary from the reserves established and any adjustments to the estimates, which may be material, are recorded in the period
they are determined.
Loss
estimates may also be based upon actuarial and statistical projections, an assessment of currently available data, predictions of
future developments, estimates of future trends and other factors. Significant assumptions used by the Company’s management
and third-party actuarial specialists include loss development factor selections, initial expected loss ratio selections, and
weighting of methods used. The final settlement of losses may vary, perhaps materially, from the reserves recorded. All adjustments
to the estimates are recorded in the period in which they are determined. U.S. GAAP does not permit establishing loss reserves,
which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result,
only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment
of loss reserves to account for expected future loss events.
Generally,
the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized
to update the initial expected loss ratio. We also experience lag between (i) claims being reported by the underlying insured to the
Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s
loss reserve estimates. Cedent reports have pre-determined due dates (for example, thirty days after each month end). As a result, the
lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company
receives premium and loss information as soon as practicable once the cedent has closed its books. Accordingly, there should be a short
lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that
such loss notifications are provided to the Company immediately upon the occurrence of an event.
Stock-Based
Compensation Expense
The
Company uses the fair-value method of accounting for stock-based compensation awards granted. The Company has determined the fair value
of its outstanding stock options on their grant date using the Black-Scholes option pricing model along with multiple Monte Carlo simulations
to determine a derived service period as the options vest based upon meeting certain performance conditions. The Company determines the
fair value of restricted stock units (“RSUs”) on their grant date using the fair value of the Company’s common stock
on the date the RSUs were issued (for those RSU which vest solely based upon the passage of time). The fair value of these awards is
recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will
vest, with a corresponding increase to additional paid-in capital. When the stock options are exercised, or correspondingly, when the
RSUs vest, the amount of proceeds together with the amount recorded in additional paid-in capital is recorded in shareholders’
equity.
Recent
Accounting Pronouncements
See
Item 8, Note 3 – Recently Adopted and Issued Accounting Standards in the Notes to the Consolidated Financial Statements for a discussion
of recent accounting pronouncements and their effect, if any, on the Company.
Analysis
of Financial Condition
As
of December 31, 2022 compared to December 31, 2021
Investments
The
table below summarizes, by type, the Company’s investments held at fair value as of December 31, 2022 and 2021.
($ in thousands) | |
| | |
| | |
| | |
| |
As of December 31, 2022 | |
Cost Basis | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Carrying Amount | |
Hagerty common stock | |
$ | 889 | | |
$ | – | | |
$ | 48 | | |
$ | 841 | |
Total investments | |
$ | 889 | | |
$ | – | | |
$ | 48 | | |
$ | 841 | |
As of December 31, 2021 | |
Cost Basis | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Carrying Amount | |
FedNat common stock | |
$ | 14,495 | | |
$ | – | | |
$ | 13,074 | | |
$ | 1,421 | |
Total investments | |
$ | 14,495 | | |
$ | – | | |
$ | 13,074 | | |
$ | 1,421 | |
Hagerty
Common Stock
On
December 15, 2022, FG Merchant Partners, LP (“FGMP”) distributed 99,999 common shares of Hagerty to the Company, which it
now owns directly. On the date of distribution, the common shares had an aggregate fair value
of approximately $889,000.
FedNat
Common Stock
The
Company sold its remaining FedNat common stock shares held in October 2022.
Deconsolidation
of Subsidiary
At
the time of the Company’s initial investment into FG Special Situations Fund, LP (“Fund”), in September 2020, the Company
had determined that its investment represented an investment in a variable interest entity (“VIE”), in which the Company
was the primary beneficiary, and, as such, had consolidated the financial results of the Fund through November 30, 2021. At each reporting
date, the Company evaluates whether it remains the primary beneficiary and continuously reconsiders that conclusion. On December 1, 2021,
the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating
policies of the Fund and accordingly derecognized the related assets, liabilities, and noncontrolling interests of the Fund as of that
date. The Company did not receive any consideration in the deconsolidation of the Fund, nor did it record any gain, or loss upon deconsolidation.
The assets and liabilities of the Fund, over which the Company lost control are as follows:
As of December 1, 2021 (in thousands) | |
| |
Cash and cash equivalents | |
$ | 100 | |
Investments in private placements | |
| 15,734 | |
Investments in public SPACs | |
| 22 | |
Other assets | |
| 18 | |
Other liabilities | |
| (34 | ) |
Net assets deconsolidated | |
$ | 15,840 | |
While
the Company’s investments in the Fund are no longer consolidated, the Company has retained its interest in all of the investments
held at the Fund. Accordingly, the Company has not presented its investment in the Fund as a discontinued operation. Effective December
1, 2021, the Company began accounting for its investment in the Fund under the equity method of accounting.
Equity
Method Investments
Other
investments on the Company’s Consolidated Balance Sheets consists of equity method investments, which as of December 31, 2022,
includes our investment in FGMP and the Fund.
On
January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners,
as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited
partner interest in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched under our SPAC
Platform as well as merchant banking initiatives. For the twelve months ended December 31, 2022, the Company has contributed $0.1 million
into FGMP, and has received distributions in the approximate amount of $2.2 million. The Company has recorded equity method gains from
FGMP of approximately $4.0 million for the twelve months ended December 31, 2022. The carrying value of our investment in FGMP as of
December 31, 2022, was approximately $5.7 million, compared to $3.8 million as of December 31, 2021. Of the $5.7 million carrying value
of our investment in FGMP at December 31, 2022, the Company may allocate up to approximately $1.0 million to incentivize and compensate
individuals and entities for the successful merger of SPAC’s launched under our platform.
Equity
method investments also include our investment in the Fund as of December 31, 2022. Until December 1, 2021, we had consolidated the Fund
as a variable interest entity, however, effective December 1, 2021, we began accounting for this investment under the equity method of
accounting. For the twelve months ended December 31, 2022, the Company has contributed $6.7 million into the Fund, and has received cash
distributions in the approximate amount of $3.2 million. The Company has recorded equity method gains from the Fund of approximately
$3.6 million for the twelve months ended December 31, 2022. As of December 31, 2022, the carrying value of our investment in the Fund
was approximately $16.8 million, compared to $9.7 million as of December 31, 2021.
Certain
investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo
simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying
investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices
blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration
of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of
a successful merger when valuing SPAC equity.
Investments
without Readily Determinable Fair Value
In
addition to our equity method investments, other investments, as listed on our balance sheet, consist of equity we have purchased in
companies for which there do not exist readily determinable fair values. This includes the Company’s
$2.0 million direct investment in FGC. The Company accounts for these investments at their cost, subject
to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Any profit distributions the
Company receives on these investments are included in net investment income. The Company’s total investment in companies without
a readily determinable fair value was approximately $2.3 million and $0.5 million as of December 31, 2022 and 2021, respectively.
For
the years ended December 31, 2022, and 2021, the Company has received distributions of $230,000 and $101,000 on these investments, respectively.
Funds
Deposited with Reinsured Companies
“Funds
Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held by cedents provided
to support our reinsurance contracts. On November 12, 2020, Fundamental Global Reinsurance Ltd. (“FGRe”), our Cayman Islands
based reinsurance subsidiary, initially funded a trust account at Lloyd’s with approximately $2.4 million cash, to collateralize
its obligations under a quota-share agreement with a Funds at Lloyd syndicate. The initial contract covered our quota share percentage
of all risks written by the syndicate for the 2021 calendar year. On November 30, 2021, we entered into an agreement with the same syndicate,
slightly increasing our quota-share percentage of the risks the syndicate writes for the 2022 calendar year. This resulted in FGRe’s
depositing additional collateral of approximately $1.0 million into the account. In June 2022, FGRe received approximately $0.4 million
in a partial return of initial collateral. In December 2022, we entered into another agreement with the syndicate, slightly increasing
our quota-share percentage of the risks the syndicate writes for the 2023 calendar year. This resulted in FGRe depositing additional
collateral of approximately $2.4 million in cash to the account.
During
2021, we also deposited cash collateral in the approximate amount of $1.0 million, to support our automotive insurance quota-share agreement
entered on April 1, 2021. We entered into an additional agreement with the same automotive insurance company on April 1, 2022, and in
the third quarter of 2022, we deposited additional collateral of approximately $0.2 million.
In
the third quarter of 2022, FGRe deposited cash collateral of approximately $1.1 million and deposited approximately $1.4 million in premiums
received from the cedent, to support the homeowners’ property catastrophe excess of loss reinsurance contract that became effective
April 1, 2022. The cash is held in a segregated account until such time that the Company’s liability for losses ascribed have been
commuted, or all losses have been closed or settled for this contract. The named tropical storm season started on June 1, 2022 and ended
on November 30, 2022.
During
2022, the Company also deposited collateral of approximately $0.1 million to support the startup homeowners insurance quota-share agreement,
and deposited additional collateral of approximately $0.1 million to support the specialty insurance company that provides hired and
non-owned automotive insurance quota share-agreement.
As
of December 31, 2022, and December 31, 2021, the total cash collateral on deposit to support all our reinsurance treaties was approximately
$9.3 million and $4.4 million, respectively.
In
January 2023, the losses ascribed were commuted for the homeowners’ property catastrophe excess of loss reinsurance contract that
became effective April 1, 2022. This resulted in $2.5 million of collateral being returned to the Company.
Current
Income Taxes Recoverable
Current
income taxes recoverable were $0 as of December 31, 2022 and December 31, 2021, representing the estimate of both the Company’s
state and federal income taxes receivable as of each date. In the third quarter of 2021, we received a refund on our federal taxes in
the amount of approximately $1.5 million associated with a carryback refund request filed for our 2018, 2017 and 2014 tax years.
Reinsurance
Balances Receivable
Reinsurance
balances receivable were $9.3 million as of December 31, 2022, compared to $3.9 million as of December 31, 2021, representing net amounts
due to the Company under our quota-share agreements. As the Company estimates the ultimate premiums, loss expenses and other costs associated
with some of these contracts, based on information received by us from the ceding companies, a significant portion of this balance is
based on estimates and, ultimately, may not be collected by the Company.
Net
Deferred Taxes
Deferred
income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting
purposes, as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are
$9.1 million and $3.6 million, respectively, as of December 31, 2022. The Company has recorded a valuation allowance against its deferred
tax assets of $5.5 million, as of December 31, 2022, due to the uncertain nature surrounding our ability to realize these tax benefits
in the future. Significant components of the Company’s net deferred taxes are as follows:
($ in thousands) | |
As of December 31, | |
| |
2022 | | |
2021 | |
Deferred income tax assets: | |
| | | |
| | |
Net operating loss carryforward | |
$ | 4,171 | | |
$ | 3,010 | |
Loss and loss adjustment expense reserve | |
| 39 | | |
| 25 | |
Unearned premium reserves | |
| 287 | | |
| 152 | |
Capital loss carryforward | |
| 4,313 | | |
| 1,114 | |
Share-based compensation | |
| 242 | | |
| 253 | |
Investments | |
| 5 | | |
| 1,692 | |
Other | |
| 9 | | |
| 3 | |
Deferred income tax assets | |
$ | 9,066 | | |
$ | 6,249 | |
Less: Valuation allowance | |
| (5,463 | ) | |
| (5,715 | ) |
Deferred income tax assets net of valuation allowance | |
$ | 3,603 | | |
$ | 534 | |
| |
| | | |
| | |
Deferred income tax liabilities: | |
| | | |
| | |
Investments | |
$ | 3,282 | | |
$ | 369 | |
Deferred policy acquisition costs | |
| 321 | | |
| 165 | |
Deferred income tax liabilities | |
$ | 3,603 | | |
$ | 534 | |
| |
| | | |
| | |
Net deferred income tax asset (liability) | |
$ | – | | |
$ | – | |
As
of December 31, 2022, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately
$19.9 million, which will be available to offset future taxable income. Approximately $0.5 million will expire on December 31, 2039,
$0.2 million will expire on December 31, 2040, and $1.6 million of the Company’s NOLs will expire on December 31, 2041. The remaining
$17.6 million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $20.5 million
of capital loss carryforward that can only be used to offset capital gains, and which will expire in December 2026 if not used prior.
Loss
and Loss Adjustment Expense Reserves
A
significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for
loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties
and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing
the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s
management, Company’s outside actuaries, as well as the management of ceding companies and their actuaries.
In
estimating losses, the Company may assess any of the following:
● |
a
review of in-force treaties that may provide coverage and incur losses; |
|
|
● |
general
forecasts, catastrophe and scenario modelling analyses and results shared by cedents; |
|
|
● |
reviews
of industry insured loss estimates and market share analyses; and |
|
|
● |
management’s
judgment. |
Assumptions
which served as the basis for the Company’s estimates of reserves for the COVID-19 pandemic losses and LAE include:
● |
Loss development factor selections, initial expected loss ratio selections,
and weighting of methods used; |
|
|
● |
the
scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage; |
|
|
● |
the
regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry; |
|
|
● |
the
extent of economic contraction caused by the COVID-19 pandemic and associated actions; and |
|
|
● |
the
ability of the cedents and insured to mitigate some or all of their losses. |
Under
the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims
being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to
the Company. This lag may impact the Company’s loss and LAE reserve estimates. The reports we receive from our cedents have pre-determined
due dates. In the case of the Company’s FAL contract, fourth quarter 2022 premium and loss information was not made available to
the Company in a manner that allowed for the timely filing of this annual report. Thus, our fourth quarter results, including the loss
and LAE reserves presented herein, have been based upon a combination of first, second, and third quarter actual results as well as full-year
forecasts reported to us by the ceding companies, which we used to approximate fourth quarter results. The Company obtains regular updates
of premium and loss related information for the current and historical periods, which we use to update the initial expected loss ratios
on our reinsurance contracts.
While
the Company believes its estimate of loss and LAE reserves are adequate as of December 31, 2022, based on available information, actual
losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness
of its assumptions as new information is provided.
A
summary of changes in outstanding loss and LAE reserves for the twelve months ended December 31, 2022, and 2021, is as follows:
(in thousands) | |
Twelve months ended December 31, | |
| |
2022 | | |
2021 | |
Balance, beginning of period | |
$ | 2,133 | | |
$ | – | |
Incurred related to: | |
| – | | |
| – | |
Current year | |
| 6,628 | | |
| 4,338 | |
Prior year | |
| 856 | | |
| – | |
Paid related to: | |
| | | |
| | |
Current year | |
| (3,822 | ) | |
| (2,205 | ) |
Prior years | |
| (1,386 | ) | |
| – | |
Balance, December 31 | |
$ | 4,409 | | |
$ | 2,133 | |
Off
Balance Sheet Arrangements
None.
Shareholders’
Equity
8.00%
Cumulative Preferred Stock, Series A
On
May 21, 2021, we completed the underwritten public offering of an additional 194,580 shares of our preferred stock designated as 8.00%
Cumulative Preferred Stock, Series A, par value $25.00 per share (the “Series A Preferred Stock”), for net proceeds of approximately
$4.2 million. As of December 31, 2022, the total number of Series A Preferred Stock shares outstanding was 894,580.
Dividends
on the Series A Preferred Stock are cumulative from the date of original issue and are payable quarterly on the 15th day of March, June,
September and December of each year, when, as and if declared by our Board of Directors. Dividends are payable out of amounts legally
available therefor at a rate equal to 8.00% per annum per $25.00 of stated liquidation preference per share, or $2.00 per share of Series
A Preferred Stock per year. Our Board of Directors declared the first quarter 2023 dividend on the shares of Series A Preferred Stock
on February 1, 2023. The Series A Preferred Stock shares trade on the Nasdaq Stock Market under the symbol “FGFPP”.
Common
Stock
In
the fourth quarter of 2021, we sold a total of 750,000 shares of our common stock, at a price of $4.00 per share, for net proceeds of
approximately $2.5 million. Also in the fourth quarter, the Company completed a rights’ offering to holders of its common stock.
Pursuant to the rights offering, 691,735 shares were subscribed for, for net proceeds of approximately $2.7 million. The Company intends
to use the net proceeds from the issuance of its common shares for working capital and other general corporate purposes.
In
June 2022, we sold a total of 2,750,000 shares of our common stock in an underwritten public offering, at a price of $1.58 per share,
for net proceeds of approximately $3.8 million. On August 2, 2022, ThinkEquity, the underwriter with respect to the public offering,
partially exercised its overallotment option and we sold an additional 71,770 shares of our common stock, at a price of $1.58 per share,
for net proceeds of $0.1 million. The Company intends to use the net proceeds from the underwritten public offering for working capital
and other general corporate purposes.
On
November 3, 2022, the Company entered into a Sales Agreement with ThinkEquity LLC, pursuant to which the Company may offer and sell,
from time to time through ThinkEquity LLC, shares of the Company’s common stock, having an aggregate offering price of up to $2,575,976,
subject to the terms and conditions of the Sales Agreement. The Company filed a prospectus supplement to its registration statement on
Form S-3. Under the Sales Agreement, the ThinkEquity LLC may sell the Shares in sales deemed to be an “at-the-market offering”
as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933. The Company is not obligated to make any sales of the shares
under the Sales Agreement. As of December 31, 2022, the Company had not yet sold any shares under this Sales Agreement.
Retirement
of Treasury Stock
On
August 19, 2021, the Board approved the retirement of all 1,281,511 common stock treasury shares owned by the Company. Accordingly, these
shares have been classified as authorized, but unissued shares on the Company’s balance sheet, as of December 31, 2021.
Change
in Shareholders’ Equity
The
table below presents the primary components of changes to total shareholders’ equity for the years ended December 31, 2022 and
2021:
| |
Preferred Shares Outstanding | | |
Common Shares Outstanding | | |
Treasury
Shares | | |
Total Shareholders’ Equity. | |
Balance, January 1, 2021 | |
| 700,000 | | |
| 4,988,310 | | |
| 1,281,511 | | |
$ | 34,193 | |
Retirement of Treasury Stock | |
| - | | |
| - | | |
| (1,281,511 | ) | |
| - | |
Stock compensation | |
| – | | |
| 67,160 | | |
| – | | |
| 559 | |
Series A Preferred Share issuance | |
| 194,580 | | |
| | | |
| | | |
| 4,217 | |
Dividends declared on Series A Preferred Stock | |
| – | | |
| – | | |
| – | | |
| (1,692 | ) |
Issuance of common stock | |
| | | |
| 1,441,735 | | |
| | | |
| 5,246 | |
Net loss | |
| – | | |
| – | | |
| – | | |
| (8,514 | ) |
Balance, December 31, 2021 | |
| 894,580 | | |
| 6,497,205 | | |
| – | | |
$ | 34,009 | |
| |
| | | |
| | | |
| | | |
| | |
Balance, January 1, 2022 | |
| 894,580 | | |
| 6,497,205 | | |
| – | | |
$ | 34,009 | |
Stock compensation | |
| – | | |
| 91,498 | | |
| – | | |
| 255 | |
Dividends declared on Series A Preferred Stock | |
| – | | |
| – | | |
| – | | |
| (1,789 | ) |
Issuance of common stock | |
| – | | |
| 2,821,770 | | |
| – | | |
| 3,732 | |
Net income | |
| – | | |
| – | | |
| – | | |
| 1,088 | |
Balance, December 31, 2022 | |
| 894,580 | | |
| 9,410,473 | | |
| – | | |
$ | 37,295 | |
Results
of Operations
Year
Ended December 31, 2022 Compared to Year Ended December 31, 2021
Net
Premiums Earned
Net
premiums earned represent actual premiums earned on our reinsurance agreements as well as estimated premiums earned on our FAL
agreement as disclosed previously. All actual and estimated premiums earned are the result of property and casualty assumed premium.
For the twelve months ended December 31, 2022 and 2021, earned premiums are approximately $13.0 million and $4.9 million,
respectively. The increase in reinsurance premiums was due primarily to the additional reinsurance agreements signed during the
current year.
Net
Investment Income
Net
investment income for the years ended December 31, 2022 and 2021 is as follows:
(in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Investment income (loss): | |
| | | |
| | |
Realized loss on FedNat common stock | |
$ | (13,797 | ) | |
$ | (5,452 | ) |
Unrealized holding loss on Hagerty common stock | |
| (48 | ) | |
| - | |
Unrealized holding gain on private placement investments | |
| - | | |
| 5,267 | |
Change in unrealized holding loss on FedNat common stock | |
| 13,074 | | |
| (865 | ) |
Equity method earnings | |
| 7,618 | | |
| 3,448 | |
Other (loss) income | |
| (70 | ) | |
| 147 | |
Net investment income | |
$ | 6,777 | | |
$ | 2,545 | |
Other
Income
Other
income was approximately $320,000, compared to $186,000, for the years ended December 31, 2022, and 2021, respectively, and is comprised
of fees earned under the investment advisory and transition services agreements between the Company and FedNat. Also included in other
income for the twelve months ended December 31, 2022 and 2021 is service fee revenue we have earned under our SPAC Platform, whereby
we provide certain accounting, regulatory, strategic, advisory, and other administrative services.
Net
Losses and Loss Adjustment Expenses
Net
losses and LAE for the twelve months ended December 31, 2022 and 2021, were $7.5 million and $4.3 million, respectively. The increase
in net losses and loss adjustment expenses was due primarily to the additional reinsurance agreements signed during the current year.
As discussed under Note 5, Loss and Loss Adjustment Expense Reserves, a portion of this charge represents an estimate based upon a full
calendar year forecast of results provided to us by the ceding companies under our FAL arrangements.
General
and Administrative Expenses
General
and administrative expenses decreased by $0.8 million to $8.4 million for the twelve months ended December 31, 2022, compared to $9.2
million for the twelve months ended December 31, 2021. The decrease was primarily due to lower legal and professional fees, stock compensation
expense and salaries and benefits for the year ended December 31, 2022.
Also
included in general and administrative expenses are payments to Fundamental Global Management, LLC (“FGM”), pursuant to a
shared services agreement entered into on March 31, 2020. Under the agreement, FGM provides the Company with certain services related
to the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial
and operational performance, providing a management team to supplement the executive officers of the Company, and such other services
consistent with those customarily performed by executive officers and employees of a public company. In exchange for these services,
the Company pays FGM a fee of approximately $456,000 per quarter, plus reimbursement of expenses incurred by FGM in connection with the
performance of the services, subject to certain limitations approved by the Company’s Board of Directors or Compensation Committee,
from time to time. The Company paid $1.8 million and $1.8 million to FGM under the agreement, for the years ended December 31, 2022 and
2021, respectively. FGM is an affiliate of FG, the Company’s largest shareholder.
Income
Tax Expense (Benefit)
Our
actual effective tax rate varies from the statutory federal income tax rates as shown in the following table.
($ in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
| |
Amount | | |
% | | |
Amount | | |
% | |
| |
| | |
| | |
| | |
| |
Provision for taxes at U.S. statutory marginal income tax rate of 21% | |
$ | 229 | | |
| 21.0 | % | |
$ | (1,540 | ) | |
| 21.0 | % |
Valuation allowance for deferred tax assets deemed unrealizable | |
| (252 | ) | |
| (23.1 | )% | |
| 1,782 | | |
| (24.3 | )% |
State income tax (net of federal benefit) | |
| – | | |
| – | % | |
| (114 | ) | |
| 1.6 | % |
Minority Interest | |
| – | | |
| – | % | |
| (279 | ) | |
| 3.8 | % |
Other | |
| 23 | | |
| 2.1 | % | |
| 6 | | |
| (0.1 | )% |
Income tax benefit | |
$ | – | | |
| – | % | |
$ | (145 | ) | |
| 2.0 | % |
| |
| | | |
| | | |
| | | |
| | |
Income tax benefit – from continuing operations | |
$ | – | | |
| – | % | |
$ | – | | |
| – | % |
Income tax benefit – from discontinued operations | |
$ | – | | |
| – | % | |
$ | (145 | ) | |
| 2.0 | % |
Due
to the sale of our former insurance business, these operations have been classified as discontinued operations in the Company’s
financial statements presented herein. For the year ended December 31, 2021, we recognized a gain from the sale of these operations of
approximately $145,000, related to a final true-up and settlement for income taxes due to the Company under the sale agreement.
We
have also recorded a benefit of $252,000 and a charge of $1.8 million for the years ended December 31, 2022 and 2021, respectively, as
a valuation allowance against all of our net deferred tax assets, due to uncertainty regarding our ability to realize these tax benefits
in the future, reducing the net deferred income tax asset to $0, as of December 31, 2022.
Net
Loss
Information
regarding our net loss and loss per share for the years ended December 31, 2022 and 2021 is as shown in the following table:
($ in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Basic and diluted: | |
| | | |
| | |
Net income (loss) from continuing operations | |
$ | 1,088 | | |
$ | (7,333 | ) |
Loss attributable to noncontrolling interest | |
| - | | |
| (1,326 | ) |
Dividends declared on Series A Preferred Shares | |
| (1,789 | ) | |
| (1,692 | ) |
Loss attributable to FG Financial Group, Inc. common shareholders | |
| (701 | ) | |
| (10,351 | ) |
Weighted average common shares | |
| 8,030,106 | | |
| 5,212,772 | |
Loss per common share from continuing operations | |
$ | (0.09 | ) | |
$ | (1.99 | ) |
| |
| | | |
| | |
Gain on sale of former insurance business | |
$ | - | | |
$ | (145 | ) |
Weighted average common shares outstanding | |
| 8,030,106 | | |
| 5,212,772 | |
Income per common share from discontinued operations | |
$ | - | | |
$ | 0.03 | |
| |
| | | |
| | |
Loss per share attributable to common shareholders | |
$ | (0.09 | ) | |
$ | (1.96 | ) |
Liquidity
and Capital Resources
The
purpose of liquidity management is to ensure that there is sufficient cash to meet all financial commitments and obligations as they
fall due. The liquidity requirements of the Company and its subsidiaries have been met primarily by funds generated from operations and
from the proceeds from the sales of our common and preferred stock. Cash provided from these sources has historically been used for making
investments, loss and LAE payments, as well as other operating expenses.
Cash
Flows
The
following table summarizes the Company’s consolidated cash flows for the years ended December 31, 2022 and 2021:
($ in thousands) | |
Year ended December 31, | |
Summary of Cash Flows | |
2022 | | |
2021 | |
Cash and cash equivalents – beginning of period | |
$ | 15,542 | | |
$ | 12,132 | |
| |
| | | |
| | |
Net cash used by operating activities | |
| (11,022 | ) | |
| (14,406 | ) |
Net cash (used) provided by investing activities | |
| (3,453 | ) | |
| 5,898 | |
Net cash provided by financing activities | |
| 1,943 | | |
| 11,918 | |
Net (decrease) increase in cash and cash equivalents | |
| (12,532 | ) | |
| 3,410 | |
| |
| | | |
| | |
Cash and cash equivalents – end of period | |
$ | 3,010 | | |
$ | 15,542 | |
For
the year ended December 31, 2022, the Company’s net cash used by operating activities was approximately $11.0 million, the major
drivers of which were as follows:
|
● |
Our
net income of approximately $1.1 million for the year. |
|
● |
Approximately
$13.0 million for a non-cash charge related to the change in unrealized holding loss on our
equity investments, and approximately $7.6 for a non-cash charge related to income from equity
method investments, offset by $13.9 million in realized loss on sale associated with our
shares of FedNat common stock. |
|
● |
A
cash outflow of approximately $5.4 million representing cash placed in trust as collateral, pursuant to our quota-share agreements. |
For
the year ended December 31, 2022, the Company’s net cash used by investing activities primarily consists of approximately $8.8
million from the purchase of other investments, offset by sales of other investments in the amount of $4.7 million and $0.7 million from
the sale of equity securities.
For
the year ended December 31, 2022, the Company’s net cash provided by financing activities consist of proceeds of approximately
$3.7 million from the issuance of common stock, offset by the payments of dividends in the amount of $1.8 million on our Series A Preferred
Shares.
For
the year ended December 31, 2021, the Company’s net cash used by operating activities was approximately $14.4 million, the major
drivers of which were as follows:
|
● |
Our
net loss of approximately $7.2 million for the year. |
|
● |
Approximately
$7.8 million for a non-cash charge related to the unrealized holding gains on our various investments, offset by $5.5 million in
realized loss on sale associated with our shares of FedNat common stock. |
|
● |
A
cash outflow of approximately $2.0 million representing cash placed in trust as collateral, pursuant to our quota-share agreements. |
|
● |
A
cash outflow of approximately $6.5 million for our investment in our SPAC sponsorships through the Fund. As this investment was made
by our former investment company subsidiary, we are required to show these cash outflows as operating activities. |
For
the year ended December 31, 2021, the Company’s net cash provided by investing activities consist primarily of proceeds of approximately
$5.9 million from the sale of a portion of our FedNat shares as well as the complete liquidation of our Metrolina investment.
For
the year ended December 31, 2021, the Company’s net cash used by financing activities consist of was approximately $11.9 million,
the major drivers of which were as follows:
|
● |
The
payments of dividends in the amount of $1.7 million on our Series A Preferred Shares. |
|
● |
Net
proceeds from the issuance of our Series A Preferred Shares in the amount of approximately $4.2 million. |
|
● |
Net
proceeds from the issuance of our common stock in the amount of approximately $5.2 million. |
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FG
FINANCIAL GROUP, INC.
Report
of Independent Registered Public Accounting Firm
Shareholders
and Board of Directors
FG
Financial Group, Inc.
Itasca,
Illinois
Opinion
on the Consolidated Financial Statements
We
have audited the accompanying consolidated balance sheets of FG Financial Group, Inc. (the “Company”) as of December 31,
2022 and 2021, the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the two years
in the period ended December 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December
31, 2022, in conformity with accounting principles generally accepted in the United States of America.
Basis
for Opinion
These
consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion
on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.
We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.
Critical
Audit Matters
The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are
material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole,
and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the
accounts or disclosures to which they relate.
Loss
and Loss Adjustment Expense Reserves (Loss Reserves)
As
described in Note 2 and Note 5 to the Company’s consolidated financial statements, loss and loss adjustment reserve estimates are
based primarily on estimates derived from reports the Company has received from ceding companies and their actuarial teams. As of December
31, 2022, the Company’s loss and loss adjustment expense reserve was $4.4 million. The Company also engages independent actuarial specialists
in order to assist management in establishing appropriate reserves. The estimate of loss reserves relies on several key judgments, including
(1) the types of exposures and projected ultimate premium to be written by cedents; (2) expected loss ratios by type of business; (3)
actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and
(4) general economic conditions.
We
identified the actuarial methodologies and significant assumptions used in the estimation of the Company’s loss and loss adjustment
expense reserves as a critical audit matter. The principal considerations for this determination were (i) the significant judgment by
management when developing their estimate, (ii) the significant auditor subjectivity and judgment involved in evaluating the audit evidence
related to the actuarial methodologies used, and (iii) the extent of specialized skills and knowledge needed from our actuarial specialists.
The
primary procedures we performed to address this critical audit matter included:
|
● |
Testing
the completeness and accuracy of the source information used by the Company’s management and independent actuarial specialists
to calculate loss reserves. |
|
● |
Utilizing
personnel with specialized knowledge and skill in actuarial methods to assist in (i) evaluating the appropriateness of methodologies
used, and (ii) evaluating the reasonableness of significant assumptions used by Company’s management and independent actuarial
specialists, specifically the loss development factor selections, initial expected loss ratio selections, and weighting of methods
used. |
|
● |
Comparing
the results of the reserve study prepared by independent actuarial specialists to management’s best estimate and evaluating
the differences. |
Valuation
of Equity Method Investments
As
described in Note 4 to the consolidated financial statements, the Company’s equity method investments include private placement
investments held in sponsor shares and warrants for special purpose acquisition companies (SPAC), which are estimated using complex valuation
methods (Monte-Carlo simulation and option pricing models) and involves significant assumptions.
We
identified the valuation methodologies and significant assumptions utilized in the estimation of the fair value of these private placement
investments as a critical audit matter. The principal considerations for this determination were the subjective and complex auditor judgment,
including the involvement of our valuation specialists in evaluating the (i) relevant valuation methodologies and (ii) significant assumptions
used in determining the fair value of these investments.
The
primary procedures we performed to address this critical audit matter included:
|
● |
Testing
the completeness and accuracy of the source information used to value the equity method investments. |
|
● |
Utilizing
personnel with specialized knowledge and skill in valuation techniques to assist in (i) evaluating the appropriateness of management’s
valuation methodologies, and (ii) evaluating the reasonableness of the significant assumptions, specifically the estimate of the
volatility of the common stock based on the selection of historical performance of various broad market indices blended with various
peer companies, the discount for lack of marketability, and the probability of a successful merger. |
/s/
BDO USA, LLP |
|
|
|
We
have served as the Company’s auditor since 2012. |
|
|
|
Grand
Rapids, Michigan |
|
|
|
March
24, 2023 |
|
FG
FINANCIAL GROUP, INC.
Consolidated
Balance Sheets
($
in thousands, except per share data)
See
accompanying notes to consolidated financial statements.
FG
FINANCIAL GROUP, INC.
Consolidated
Statements of Operations
($
in thousands, except per share data)
See
accompanying notes to consolidated financial statements.
FG
FINANCIAL GROUP, INC.
Consolidated
Statements of Shareholders’ Equity
($
in thousands)
FG
FINANCIAL GROUP, INC.
Consolidated
Statements of Cash Flows
($
in thousands)
See
accompanying notes to consolidated financial statements.
Note
1. Nature of Business
FG
Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant
banking and asset management holding company. We focus on opportunistic collateralized and loss capped reinsurance, while allocating
capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking
activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also
provides asset management services. From our inception in October 2012 through December 2019, we operated as an insurance holding company,
writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three
former insurance subsidiaries, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.
As
of December 31, 2022, Fundamental Global GP, LLC (“FG”), a private partnership focused on long-term strategic holdings, and
its affiliated entity, collectively beneficially owned approximately 60.0% of our common stock. D. Kyle Cerminara, Chairman of our Board
of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.
Sale
of the Insurance Business
On
December 2, 2019, we completed the sale (“Asset Sale”) of our insurance subsidiaries to FedNat Holding Company for a combination
of cash and FedNat common stock. The Company sold its remaining FedNat common stock shares held in October 2022.
Reincorporation
Effective
at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the
“Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly
owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders
began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws.
The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.
Other
than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management,
assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including
the Company’s management.
The
Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the
Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00%
Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”
Current
Business
Our
strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking
activities with asymmetrical risk/reward opportunities. As part of our refined focus, we have adopted the following capital allocation
philosophy:
“Grow
intrinsic value per share with a long-term focus using fundamental research, allocating capital to
asymmetric risk/reward opportunities.”
Currently,
the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special purpose acquisition corporation
“SPAC” Platform businesses, and our merchant banking division.
Insurance
Sponsor
Protection Coverage and Risk, Inc. is being formed as a special purpose captive in South Carolina to provide reinsurance coverage for
Sides A, B, & C Directors and Officers Liability insurance coverage for related and unrelated entities of Fundamental Global Reinsurance
Ltd (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as
small cap businesses performing an initial public offering.
Reinsurance
The
Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and
casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised)
of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”).
The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which
are not fully collateralized. FGRe participates in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate
during the 2021 and 2022 calendar years, and on December 10, 2022 agreed to cover risks written by the syndicate during the calendar
year 2023. On April 1, 2021, FGRe entered its second reinsurance contract with a leading insurtech company that provides automotive insurance
utilizing driver monitoring to predictively segment and price drivers. The Company added a second agreement with the automotive insurance
provider as of April 1, 2022. Beginning January 1, 2022, FGRe participates in a quota share reinsurance contract with a startup homeowners’
insurance company. On April 1, 2022, FGRe entered a homeowners’ property catastrophe excess of loss reinsurance contract with a
specialty insurance company covering loss occurrences from named tropical storms arising out of the Atlantic. On July 1, 2022, FGRe entered
a contract with a specialty insurance company that provides hired and non-owned automotive insurance. These agreements limit exposure
by loss-caps stipulated within the reinsurance contracts.
Asset
Management
FG
Strategic Consulting, LLC, (“FGSC”) a wholly-owned subsidiary of the Company, looks to provide investment advisory services,
including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization,
recommending investment dispositions, and providing advice regarding macro-economic conditions.
SPAC
Platform
On
December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company,
to facilitate the launch of our “SPAC Platform”. Under the SPAC Platform, we provide various strategic, administrative, and
regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant
Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs. The
Company also participates in the risk capital investments associated with the launch of such SPACs through its Asset Management business,
specifically FG Special Situations Fund, LP (“Fund”). As discussed in Note 4, the Company had consolidated the results of
the Fund through November 30, 2021; however, effective December 1, 2021, the Company began accounting for its investment in the Fund
under the equity method. The first transaction entered under the SPAC Platform occurred on January 11, 2021, by and among FGMS and Aldel
Investors, LLC, the sponsor of Aldel Financial, Inc. (“Aldel”), a special purpose acquisition company which completed its
business combination with Hagerty (NYSE: HGTY) on December 2, 2021. Under the services agreement between FGMS and Aldel Investors, LLC
(the “Agreement”), FGMS provided accounting, regulatory, strategic advisory, and other administrative services to Aldel,
which included assistance with negotiations with potential merger targets for the SPAC as well as assistance with the de-SPAC process.
In
March and April 2022, the Company continued to build upon its SPAC Platform strategy. On March 3, 2022, FG Merger Corp. (“FG Merger”)
(Nasdaq: FGMCU) announced the closing of an $80.5 million IPO in the United States, including the exercise of the over-allotment option
granted to the underwriters in the offering. Similarly, on April 5, 2022, FG Acquisition Corp. (“FG Acquisition”) (TSX:FGAA.V),
announced the closing of a $115 million IPO in Canada, including the exercise of the over-allotment option granted to the underwriters
in the offering. The Company participated in the risk capital associated with the launch of the SPACs through its asset management business,
specifically FG Special Situations Fund, LP. Mr. Cerminara, our Chairman, Larry G. Swets, Jr., our Director and Chief Executive Officer,
and Hassan R. Baqar, our Executive Vice President and Chief Financial Officer, also hold financial interests in the SPACs and/or their
sponsor companies. Additionally, Messrs. Cerminara, Swets, and Baqar are managers of the sponsor companies of FG Merger and FG Acquisition.
Mr. Swets serves as Chairman of FG Merger, while Messrs. Baqar and Cerminara serve as Director and Senior Advisor of FG Merger, respectively.
Mr. Swets serves as Chief Executive Officer and Director of FG Acquisition. Mr. Baqar serves as Chief Financial Officer, Secretary and
Director of FG Acquisition. Mr. Cerminara serves as Chairman of FG Acquisition.
In
the aggregate, the Company’s indirect exposure to FG Merger through its subsidiaries represents potential beneficial ownership
of approximately 820,000 shares of FG Merger’s common stock, approximately 989,000 warrants with an $11.50 exercise price and 5-year
expiration, and approximately 85,000 warrants with a $15.00 exercise price and 10-year expiration. The Company has invested approximately
$2.6 million in FG Merger through its subsidiaries. The Company’s indirect exposure in FG Acquisition through its subsidiaries
represents potential beneficial ownership of approximately 819,000 shares of FG Acquisition’s common stock, approximately 1,400,000
warrants with an $11.50 exercise price and 5-year expiration (the “FGAC Warrants”), approximately 440,000 warrants with a
$15 exercise price and 10-year expiration, and either (i) up to approximately an additional 1,600,000 FGAC Warrants, or (ii) up to approximately
$2 million in cash, or (iii) a pro-rata combination of such FGAC Warrants and cash, based on certain adjustment provisions and the level
of redemptions of FG Acquisition’s publicly traded warrants at the time of a business combination. The Company has invested approximately
$3.4 million in FG Acquisition through its subsidiaries.
Merchant
Banking
In
Q3 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division. The Company
invested $2.0 million into its first project launched under the platform, FG Communities, Inc (“FGC”). FGC is a self-managed
real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. As discussed
further in Note 4, the Company will hold this investment at cost, subject to any adjustment from time to time due to impairment or observable
price changes in orderly transactions.
Note
2. Significant Accounting Policies
Basis
of Presentation
These
statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).
Consolidation
Policies
The
accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany
balances and transactions have been eliminated upon consolidation.
The
consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either
the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting
entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal
entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered
to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than
by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly
impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that
could potentially be significant to the legal entity.
The determination of whether
or not to consolidate a variable interest entity under GAAP requires a significant amount of judgment concerning the degree of control
over an entity by its holders of variable interests. To make these judgments, management has conducted an analysis, on a case-by-case
basis, of whether we are the primary beneficiary and are therefore required to consolidate the entity. Upon the occurrence of certain
events, such as modifications to organizational documents and investment management agreements, management will reconsider its conclusion
regarding the status of an entity as a variable interest entity.
In
September 2020, the Company invested approximately $5.0 million to sponsor the launch of the Fund. The Fund, a VIE which the Company
was required to consolidate through November 30, 2021, is considered an investment company for GAAP purposes and follows the accounting
and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment
Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment
became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus,
began to account for its investment in the Fund under the equity method of accounting.
In
October of 2022, the Company invested $2.0 million into FGC, which the Company has determined meets the criteria of a VIE. The Company
holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions.
Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not
the primary beneficiary of FGC, and thus does not consolidate FGC.
The
Company’s risk of loss associated with its non-consolidated VIEs is limited. As of December 31, 2022, and December 31, 2021, the
carrying value and maximum loss exposure of the Company’s non-consolidated VIE’s was $18.8 million and $9.7 million, respectively.
See
Note 4 for additional information regarding the Company’s investments.
Discontinued
Operations
Due
to the sale of all of the issued and outstanding equity of our previous insurance business on December 2, 2019, these operations have
been classified as discontinued operations in the Company’s financial statements presented herein. For the year ended December
31, 2021, we recognized a gain from the sale of this business for approximately $145,000. This was related to a final true-up and settlement
in the first quarter of 2021, for income taxes due to the Company under the sale agreement. The following table presents a reconciliation
of the major classes of line items constituting discontinued operations that are presented in the Company’s consolidated Statements
of Operations for the years ended December 31, 2022 and 2021:
Schedule of Discontinued Operations
| |
2022 | | |
2021 | |
(in thousands) | |
Year ended December 31, | |
| |
2022 | | |
2021 | |
Gain from sale of former insurance business | |
| - | | |
| (145 | ) |
Net income from discontinued operations | |
$ | - | | |
$ | (145 | ) |
The
Use of Estimates in the Preparation of Consolidated Financial Statements
The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual
results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates
are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying
consolidated financial statements include the valuation of our investments, the valuation of net deferred income taxes and deferred policy
acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.
Investments
in Equity Securities
Investments
in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations
as a component of net investment income.
Other
Investments
Other
investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize
the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the
operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses
more than 20% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that
demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock
and to other investments when such other investments possess substantially identical subordinated interests to common stock.
In
applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment
by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other
equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount
of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not
committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our
claim on the investee’s book value.
When
we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related
cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods,
with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent
returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative
equity in earnings represent returns on investment and are classified as cash inflows from investing activities.
Other
investments also consist of equity we have purchased in a limited partnership, limited liability company, and a corporation for which
there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, subject to any adjustment
from time to time due to impairment or observable price changes in orderly transactions. Any profit distributions the Company receives
on these investments are included in net investment income.
Cash
and Cash Equivalents
Cash
and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.
Pursuant
to the Company’s insurance license, the Cayman Islands Monetary Authority (“Authority”) has required that FGRe hold
a minimum capital requirement of $200,000 in cash in a bank in the Cayman Islands which holds an “A” license issued under
the Banks and Trust Companies Act (2020 Revision).
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are
recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective
tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment.
Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance
is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are
charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the
current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).
Concentration
of Credit Risk
Financial
instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured
companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance
Corporation (“FDIC”) for up to $250,000. As of December 31, 2022, the Company held funds in excess of these FDIC insured
amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related
to these deposits.
Premium
Revenue Recognition
The
Company participates in reinsurance quota-share contracts and estimates the ultimate premiums for the contract period. These estimates
are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the
underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly
and in arrears, and thus for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums
relating to the risks underwritten during the lag period.
Premium
estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected ultimate
premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these
estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not
unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance
balances receivable” in the Company’s consolidated balance sheets represent estimated premiums written, net of commissions,
brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional
premiums due on a contract that has no remaining coverage period are earned in full when written.
Premiums
written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the
unexpired portion of reinsurance provided.
Deferred
Policy Acquisition Costs
Policy
acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal reinsurance business,
and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses
and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined
to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the
premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency
adjustments recognized during the periods presented herein.
Funds
Deposited with Reinsured Companies
“Funds
Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held by cedents provided
to support our reinsurance contracts. On November 12, 2020, Fundamental Global Reinsurance Ltd. (“FGRe”), our Cayman Islands
based reinsurance subsidiary, initially funded a trust account at Lloyd’s with approximately $2.4 million cash, to collateralize
its obligations under a quota-share agreement with a Funds at Lloyd syndicate. The initial contract covered our quota share percentage
of all risks written by the syndicate for the 2021 calendar year. On November 30, 2021, we entered into an agreement with the same syndicate,
slightly increasing our quota-share percentage of the risks the syndicate writes for the 2022 calendar year. This resulted in FGRe’s
depositing additional collateral of approximately $1.0 million into the account. In June 2022, FGRe received approximately $0.4 million
in a partial return of initial collateral. In December 2022, we entered into another agreement with the syndicate, slightly increasing
our quota-share percentage of the risks the syndicate writes for the 2023 calendar year. This resulted in FGRe depositing additional
collateral of approximately $2.4 million in cash to the account.
During
2021, we also deposited cash collateral in the approximate amount of $1.0 million, to support our automotive insurance quota-share agreement
entered on April 1, 2021. We entered into an additional agreement with the same automotive insurance company on April 1, 2022, and in
the third quarter of 2022, we deposited additional collateral of approximately $0.2 million.
In
the third quarter of 2022, FGRe deposited cash collateral of approximately $1.1 million and deposited approximately $1.4 million in premiums
received from the cedent, to support the homeowners’ property catastrophe excess of loss reinsurance contract that became effective
April 1, 2022. The cash is held in a segregated account until such time that the Company’s liability for losses ascribed have been
commuted, or all losses have been closed or settled for this contract. The named tropical storm season started on June 1, 2022 and ended
on November 30, 2022.
During
2022, the Company also deposited collateral of approximately $0.1 million to support the startup homeowners insurance quota-share agreement,
and deposited additional collateral of approximately $0.1 million to support the specialty insurance company that provides hired and
non-owned automotive insurance quota share-agreement.
As
of December 31, 2022, and December 31, 2021, the total cash collateral on deposit to support all of our reinsurance treaties was approximately
$9.3 million and $4.4 million, respectively.
In
January 2023, the losses ascribed were commuted for the homeowners’ property catastrophe excess of loss reinsurance contract that
became effective April 1, 2022. This resulted in $2.5 million of collateral being returned to the Company.
Loss
and Loss Adjustment Expense Reserves
The
Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported
claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports
the Company has received from ceding companies and their actuarial teams. The Company then uses a variety of statistical and actuarial
techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures
and projected ultimate premium to be written by our cedents; (2) expected loss ratios by type of business; (3) actuarial methodologies
which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions.
The Company also engages independent actuarial specialists in order to assist management in establishing appropriate reserves. Since
reserves are estimates, the final settlement of losses may vary from the reserves established and any adjustments to the estimates, which
may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the
reserves recorded.
U.S.
GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event
which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established,
with no allowance for the establishment of loss reserves to account for expected future loss events.
Generally,
the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized
to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the
Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s
loss reserve estimates. Cedent reports have pre-determined due dates (for example, thirty days after each month end). As a result, the
lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company
receives premium and loss information as soon as practicable once the cedent has closed its books. Accordingly, there should be a short
lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that
such loss notifications are provided to the Company immediately upon the occurrence of an event.
Stock-Based
Compensation
The
Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – Stock Compensation which requires
the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares
of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation
model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple
Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions.
The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period,
which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.
The
Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted
for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the
fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which
vest solely based upon the passage of time. The fair value of each RSU is recorded as compensation expense over the requisite service
period, which is generally the expected period over which the awards will vest.
Based
upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock
compensation expense for expected forfeitures as of December 31, 2022.
Fair
Value of Financial Instruments
The
carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other
accrued expenses approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments
in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability)
in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the
measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and
minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s
financial instruments.
Earnings
(Loss) Per Common Share
Basic
earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.
Diluted
earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants
or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings
(loss) per share if their effect is anti-dilutive.
Note
3. Recently Adopted and Issued Accounting Standards
Accounting
Standards Pending Adoption
ASU
2016-13: Financial Instruments – Credit Losses
In
June 2016, the FASB issued ASU 2016-13: Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments.
ASU 2016-13 was issued to provide financial statement users with more useful information regarding the expected credit losses on financial
instruments held as assets. Under current GAAP, financial statement recognition for credit losses on financial instruments is generally
delayed until the occurrence of the loss was probable. The amendments of ASU 2016-13 eliminate this probable initial recognition threshold
and instead reflect an entity’s current estimate of all expected credit losses. The amendments also broaden the information that
an entity must consider in developing its expected credit loss estimates for those assets measured at amortized cost by using forecasted
information instead of the current methodology which only considered past events and current conditions. Under ASU 2016-13, credit losses
on available-for-sale debt securities will be measured in a manner similar to current GAAP; however, the amendments require that credit
losses be presented as an allowance against the investment, rather than as a write-down. The amendments also allow the entity to record
reversals of credit losses in current period net income, which is prohibited under current GAAP. The amendments in this update are effective
for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted,
however smaller reporting companies, like the Company, may delay adoption until January 2023.
The
Company has evaluated their position by pooling contracts with shared risk characteristics, evaluating credit worthiness of the counterparties,
and defining exposure through contract length, total reinsurance exposure, and collateralized position. The estimated allowance to be
recorded upon adoption in January 2023 by the Company is expected to be immaterial.
Note
4. Investments and Fair Value Disclosures
The
following table summarizes the Company’s investments held at fair value as of December 31, 2022 and 2021.
Schedule
of Investments
($ in thousands) | |
| | |
| | |
| | |
| |
As of December 31, 2022 | |
Cost Basis | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Carrying Amount | |
Hagerty common stock | |
$ | 889 | | |
$ | – | | |
$ | 48 | | |
$ | 841 | |
Total investments | |
$ | 889 | | |
$ | – | | |
$ | 48 | | |
$ | 841 | |
As of December 31, 2021 | |
Cost Basis | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Carrying Amount | |
FedNat common stock | |
$ | 14,495 | | |
$ | – | | |
$ | 13,074 | | |
$ | 1,421 | |
Total investments | |
$ | 14,495 | | |
$ | – | | |
$ | 13,074 | | |
$ | 1,421 | |
Hagerty
Common Stock
On
December 15, 2022, FGMP distributed 99,999
common shares of Hagerty to the Company, which
it now owns directly. On the date of distribution, the common shares had an aggregate fair value
of approximately $889,000.
FedNat
Common Stock
During
the fourth quarter of 2022, the Company sold its remaining shares held of FedNat Holding Company. For the years ended December 31,
2022 and 2021, the Company had gross realized losses of $13.8
million and $5.5
million, respectively, associated with the sale of its FedNat shares. During the year ended December 2022, the Company recorded a
$13.1
million change in unrealized holding loss on FedNat shares, and a change in unrealized holding loss of $0.9
million for the year ended December 2021.
Deconsolidation
of Subsidiary
The
Company’s original investment in the Fund, a Delaware limited partnership, consisted of an investment as both a limited and general
partner. At the time of the Company’s initial investment into the Fund, in September 2020, the Company had determined that its
investment represented an investment in a variable interest entity (“VIE”) in which the Company was the primary beneficiary
and as such, had consolidated the financial results of the Fund through November 30, 2021. At each reporting date, the Company evaluates
whether it remains the primary beneficiary and continuously reconsiders that conclusion. On December 1, 2021, the Company no longer had
the power to govern the financial and operating policies of the Fund, and accordingly derecognized the related assets, liabilities, and
noncontrolling interests of the Fund as of that date. The Company did not receive any consideration in the deconsolidation of the Fund,
nor did it record any gain or loss upon deconsolidation as the Company carried its investment at fair value. The assets and liabilities
of the Fund, over which the Company lost control, were as follows:
Schedule
of Subsidiaries Assets
As of December 1, 2021 (in thousands) | |
| |
Cash and cash equivalents | |
$ | 100 | |
Investments in private placements | |
| 15,734 | |
Investments in public SPACs | |
| 22 | |
Other assets | |
| 18 | |
Other liabilities | |
| (34 | ) |
Net assets deconsolidated | |
$ | 15,840 | |
While
the Company’s investments in the Fund are no longer consolidated, the Company has retained its interest in all of the investments
held at the Fund. Accordingly, the Company has not presented its investment in the Fund as a discontinued operation. Effective December
1, 2021, the Company began accounting for its investment in the Fund under the equity method of accounting.
Equity
Method Investments
Other
investments on the Company’s Consolidated Balance Sheets consists of equity method investments, which as of December 31, 2022 includes
our investment in FGMP and the Fund.
On
January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners,
as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited
partner interest of approximately 48% in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched
under our SPAC Platform as well as merchant banking initiatives. For the twelve months ended December 31, 2022, the Company has contributed
$0.1 million into FGMP, and has received distributions in the approximate amount of $2.2 million. The Company has recorded equity method
gains from FGMP of approximately $4.0 million for the twelve months ended December 31, 2022. The carrying value of our investment in
FGMP as of December 31, 2022 was approximately $5.7 million compared to $3.8 million as of December 31, 2021. Of the $5.7 million carrying
value of our investment in FGMP at December 31, 2022, the Company may allocate up to approximately $1.0 million to incentivize and compensate
individuals and entities for the successful merger of SPAC’s launched under our platform.
Equity
method investments also include our investment in the Fund, in which we hold an approximately 61% limited partner interest as of December
31, 2022. Until December 1, 2021, we had consolidated the Fund as a variable interest entity, however, effective December 1, 2021, we
began accounting for this investment under the equity method of accounting. For the twelve months ended December 31, 2022, the Company
has contributed $6.7 million into the Fund, and has received cash distributions in the approximate amount of $3.2 million. The Company
has recorded equity method gains from the Fund of approximately $3.6 million for the twelve months ended December 31, 2022. As of December
31, 2022, the carrying value of our investment in the Fund was approximately $16.8 million, compared to $9.7 million as of December 31,
2021.
During
the year ended December 2021, equity method investments included our investment of $4.0 million in FGI Metrolina Property Income Fund,
LP (“Metrolina”), which invested in real estate through a real estate investment trust which was wholly owned by Metrolina.
We have recorded equity method earnings from our investment in Metrolina of approximately zero and $326,000 for the years ended December
31, 2022 and 2021, respectively. In the third quarter of 2021, Metrolina indicated that it would be liquidating and returning investor
capital. Accordingly, in the fourth quarter of 2021, we received approximately $5.0 million in cash back from the Fund, representing
our initial investment of $4.0 million plus approximately $1.0 million in distributed earnings. As a result, our investment in Metrolina
was fully liquidated as of December 31, 2021.
Financial
information for our investments accounted for under the equity method, in the aggregate, is as follows:
Schedule
of Investments Under Equity Method
| |
| | |
| |
| |
As of December 31, | |
(in thousands) | |
2022 | | |
2021 | |
Other investments | |
$ | 35,366 | | |
$ | 25,936 | |
Cash | |
| 113 | | |
| 72 | |
Other assets | |
| 165 | | |
| 16 | |
Total assets | |
| 35,644 | | |
| 26,024 | |
| |
| | | |
| | |
Accounts payable | |
$ | 65 | | |
$ | 19 | |
Total liabilities | |
| 65 | | |
| 19 | |
| |
| | |
| |
| |
For the year ended December 31, | |
| |
2022 | | |
2021 | |
Net investment income | |
$ | 11,959 | | |
$ | 15,312 | |
General and administrative expenses | |
| (154 | ) | |
| (273 | ) |
Net income | |
| 11,805 | | |
| 15,039 | |
Certain
investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo
simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying
investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices
blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration
of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of
a successful merger when valuing SPAC equity.
Investments
without Readily Determinable Fair Value
In
addition to our equity method investments, other investments, as listed on our balance sheet, consists of equity we have purchased
in companies for which there does not exist a readily determinable fair value. This includes
the Company’s $2.0 million direct investment in FGC. The Company accounts for these investments at their cost, subject
to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Any profit distributions
the Company receives on these investments are included in net investment income. The Company’s total investment in companies
without a readily determinable fair value was approximately $2.3 million
and $0.5 million
as of December 31, 2022 and 2021, respectively.
For
the years ended December 31, 2022, and 2021, the Company has received distributions of $230,000 and $101,000 on these investments, respectively.
Impairment
For
equity securities without readily determinable fair values, impairment is determined via a qualitative assessment which considers indicators
to evaluate whether the investment is impaired. Some of these indicators include a significant deterioration in the earnings performance
or asset quality of the investee, a significant adverse change in regulatory, economic or general market conditions in which the investee
operates, or doubt over an investee’s ability to continue as a going concern. If the investment is deemed to be impaired after
conducting this analysis, the Company would estimate the fair value of the investment to determine the amount of impairment loss.
For
equity method investments, such as the Company’s investments in FGMP and the Fund, evidence of a loss in value might include a
series of operating losses of an investee, the absence of an ability to recover the carrying amount of the investment, or a deterioration
in the value of the investee’s underlying assets. If these, or other indicators lead to the conclusion that there is a decrease
in the value of the investment that is other than temporary, the Company would recognize that decrease in value even though the decrease
may be in excess of what would otherwise be recognized under the equity method of accounting.
The
risks and uncertainties inherent in the assessment methodology used to determine impairment include, but may not be limited to, the following:
|
● |
the
opinions of professional investment managers and appraisers could be incorrect; |
|
|
|
|
● |
the
past operating performance and cash flows generated from the investee’s operations may not reflect their future performance;
and |
|
|
|
|
● |
the
estimated fair values for investment for which observable market prices are not available are inherently imprecise. |
We
have not recorded an impairment on our investments for either of the years ended December 31, 2022 and 2021.
Net
investment income (loss) for the years ended December 31, 2022 and 2021 is as follows:
Schedule
of Net Investment Income (Loss)
| |
| | |
| |
(in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Investment income (loss): | |
| | | |
| | |
Realized loss on FedNat common stock | |
$ | (13,797 | ) | |
$ | (5,452 | ) |
Unrealized holding loss on Hagerty common stock | |
| (48 | ) | |
| - | |
Unrealized holding gain on private placement investments | |
| - | | |
| 5,267 | |
Change in unrealized holding loss on FedNat common stock | |
| 13,074 | | |
| (865 | ) |
Equity method earnings | |
| 7,618 | | |
| 3,448 | |
Other (loss) income | |
| (70 | ) | |
| 147 | |
Net investment income | |
$ | 6,777 | | |
$ | 2,545 | |
Fair
Value Measurements
The
Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal
or most advantageous market. The FASB has issued guidance that defines fair value as the exchange price that would be received for an
asset (or paid to transfer a liability) in the principal, or most advantageous market in an orderly transaction between market participants.
This guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the
use of unobservable inputs when measuring fair value. The guidance categorizes assets and liabilities at fair value into one of three
different levels depending on the observation of the inputs employed in the measurements, as follows:
|
● |
Level
1 – inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets providing the
most reliable measurement of fair value since it is directly observable. |
|
|
|
|
● |
Level
2 – inputs to the valuation methodology which include quoted prices for similar assets or liabilities in active markets. These
inputs are observable, either directly or indirectly, for substantially the full-term of the financial instrument. |
|
|
|
|
● |
Level
3 - inputs to the valuation methodology which are unobservable and significant to the measurement of fair value. |
The
availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a variety of factors,
including the type of investment, whether the investment is new and not yet established in the marketplace, the liquidity of markets
and other characteristics specific to the individual investment. In some cases, the inputs used to measure fair value might be categorized
within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in
the hierarchy based on the lowest level input that is significant to the fair value measurement. When determining fair value, the Company
uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.
We
have valued our investment in Hagerty and FedNat at its last reported sales price as the common shares are traded on a national exchange.
They have been characterized in Level 1 of the fair value hierarchy.
Financial
instruments measured, on a recurring basis, at fair value as of December 31, 2022 and December 31, 2021 in accordance with the guidance
promulgated by the FASB are as follows.
Schedule
of Financial Instruments Measured at Fair Value
(in thousands) | |
| | |
| | |
| | |
| |
As of December 31, 2022 | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Hagerty common stock | |
$ | 841 | | |
$ | – | | |
$ | – | | |
$ | 841 | |
| |
$ | 841 | | |
$ | – | | |
$ | – | | |
$ | 841 | |
| |
| | | |
| | | |
| | | |
| | |
As of December 31, 2021 | |
| | | |
| | | |
| | | |
| | |
FedNat common stock | |
$ | 1,421 | | |
$ | – | | |
$ | – | | |
$ | 1,421 | |
| |
$ | 1,421 | | |
$ | – | | |
$ | - | | |
$ | 1,421 | |
Note
5. Loss and Loss Adjustment Expense Reserves
A
significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for
loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties
and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing
the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s
management, as well as the management of ceding companies and their actuaries.
In
estimating losses, the Company may assess any of the following:
● |
a
review of in-force treaties that may provide coverage and incur losses; |
|
|
● |
general
forecasts, catastrophe and scenario modelling analyses and results shared by cedents; |
|
|
● |
reviews
of industry insured loss estimates and market share analyses; and |
|
|
● |
management’s
judgement. |
Assumptions
which served as the basis for the Company’s estimates of reserves for the COVID-19 pandemic losses and LAE include:
● |
Loss development factor selections, initial expected loss ratio selections,
and weighting of methods used; |
|
|
● |
the
scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage; |
|
|
● |
the
regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry; |
|
|
● |
the
extent of economic contraction caused by the COVID-19 pandemic and associated actions; and |
|
|
● |
the
ability of the cedents and insured to mitigate some or all of their losses. |
Under
the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims
being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to
the Company. This lag may impact the Company’s loss reserve estimates. The reports we receive from our cedents have pre-determined
due dates. In the case of the Company’s FAL contract, fourth quarter 2022 premium and loss information was not made available to
the Company in a manner that allowed for the timely filing of this annual report. Thus, our fourth quarter results, including the loss
and LAE reserves presented herein, have been based upon a combination of first, second, and third quarter actual results as well as full-year
forecasts reported to us by the ceding companies for which we used to approximate fourth quarter results. The Company obtains regular
updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected
loss ratios on our reinsurance contracts.
While
the Company believes its estimate of loss and LAE reserves are adequate as of December 31, 2022, based on available information, actual
losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness
of its assumptions as new information is provided.
The
information about incurred and paid claims development for the year ended December 31, 2022 and 2021, is shown below. The tables also
include IBNR reserves plus expected development on reported claims. The cumulative number of reported claims has not been reported as
it is impracticable to provide this information. The ceding companies to which we provide reinsurance only report summary information
to us via a bordereau statement. This summary information does not include the number of reported claims underlying the paid and reported
losses. Therefore, it is not possible to provide this information. The information about incurred and paid claims development for the
year ended December 31, 2021 is presented as unaudited supplementary information.
Cumulative
Incurred Loss and Allocated LAE, net of reinsurance for the years ended December 31:
Schedule
of Incurred and Paid Losses Net of Reinsurance
Accident Year | |
| 2021* | | |
| 2022 | | |
| Total of IBNR Liabilities Plus Expected Development on Reported Claims | | |
Cumulative Number of Reported Claims |
2021 | |
$ | 4,338 | | |
$ | 856 | | |
$ | 205 | | |
N/A |
2022 | |
| - | | |
| 6,628 | | |
| 3,336 | | |
N/A |
Total – All Lines | |
$ | 4,338 | | |
$ | 7,484 | | |
$ | 3,541 | | |
N/A |
Cumulative
Paid Loss and Allocated LAE, net of reinsurance for the years ended December 31:
Accident Year | |
| 2021* | | |
| 2022 | |
2021 | |
$ | 2,205 | | |
$ | 1,386 | |
2022 | |
| - | | |
| 3,822 | |
Total – All Lines | |
$ | 2,205 | | |
$ | 5,208 | |
A
reconciliation of the net incurred and paid loss development tables to the liability for loss and loss adjustment expenses on the Company’s
consolidated balance sheets is as follows:
Schedule
of Reconciliation of Net Incurred and Paid Loss Development to Liability for Loss and Loss Adjustment Expenses
(in thousands) | |
As
of December 31, 2022 | | |
As of December 31,
2021 | |
Net Outstanding Liabilities | |
| | | |
| | |
Liability for unpaid loss and LAE | |
$ | 4,409 | | |
$ | 2,133 | |
Total gross liability for unpaid claims and LAE | |
$ | 4,409 | | |
$ | 2,133 | |
A
summary of changes in outstanding loss and loss adjustment expense reserves for the year ended December 31, 2022 and 2021 is as follows:
Schedule
of Changes in Outstanding Loss Adjustment Expense Reserves
(in thousands) | |
Year ended
December 31, 2022 | | |
Year ended
December 31, 2021 | |
Balance, January 1 | |
$ | 2,133 | | |
$ | – | |
Incurred related to: | |
| | | |
| | |
Current year | |
| 6,628 | | |
| 4,338 | |
Prior years | |
| 856 | | |
| – | |
Paid related to: | |
| | | |
| | |
Current year | |
| (3,822 | ) | |
| (2,205 | ) |
Prior years | |
| (1,386 | ) | |
| – | |
Balance, December 31 | |
$ | 4,409 | | |
$ | 2,133 | |
The
following is unaudited supplementary information about average historical claims duration as of December 31, 2022:
Schedule
of Supplementary Information of Average Historical Claims Duration
Average Annual Percentage Payout of
Incurred Losses by Age, Net of Reinsurance (unaudited) |
Age of loss (in years) | |
| 1 | | |
| 2 | | |
| 3 | | |
| 4 | | |
| 5 | | |
| 6 | |
All Lines | |
| 51.0 | % | |
| 11.7 | % | |
| - | % | |
| - | % | |
| - | % | |
| - | % |
Note
6. Income Taxes
A
summary of income tax expense (benefit) is as follows:
Summary
of Income Tax Expense (Benefit)
| |
2022 | | |
2021 | |
($ in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Total income tax benefit – from discontinued operations | |
$ | - | | |
$ | (145 | ) |
Total income tax benefit | |
$ | - | | |
$ | (145 | ) |
Actual
income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax
rates to income before income tax expense as follows:
Schedule
of Reconciliation Effective Tax Rates
($ in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
| |
Amount | | |
% | | |
Amount | | |
% | |
| |
| | |
| | |
| | |
| |
Provision for taxes at U.S. statutory marginal income tax rate of 21% | |
$ | 229 | | |
| 21.0 | % | |
$ | (1,540 | ) | |
| 21.0 | % |
Valuation allowance for deferred tax assets deemed unrealizable | |
| (252 | ) | |
| (23.1 | )% | |
| 1,782 | | |
| (24.3 | )% |
State income tax (net of federal benefit) | |
| - | | |
| - | % | |
| (114 | ) | |
| 1.6 | % |
Non-controlling interest | |
| - | | |
| - | % | |
| (279 | ) | |
| 3.8 | % |
Other | |
| 23 | | |
| 2.1 | % | |
| 6 | | |
| (0.1 | )% |
Income tax benefit | |
$ | - | | |
| - | % | |
$ | (145 | ) | |
| 2.0 | % |
Deferred
income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting
purposes as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are $9.1
million and $3.6 million as of December 31, 2022. The Company has recorded a valuation allowance against its deferred tax assets of $5.5
million, as of December 31, 2022, due to the uncertain nature surrounding our ability to realize these tax benefits in the future. Significant
components of the Company’s net deferred tax assets are as follows:
Schedule
of Deferred Income Taxes
| |
2022 | | |
2021 | |
($ in thousands) | |
As of December 31, | |
| |
2022 | | |
2021 | |
Deferred income tax assets: | |
| | | |
| | |
Net operating loss carryforward | |
$ | 4,171 | | |
$ | 3,010 | |
Loss and loss adjustment expense reserves | |
| 39 | | |
| 25 | |
Unearned premium reserves | |
| 287 | | |
| 152 | |
Capital loss carryforward | |
| 4,313 | | |
| 1,114 | |
Share-based compensation | |
| 242 | | |
| 253 | |
Investments | |
| 5 | | |
| 1,692 | |
Other | |
| 9 | | |
| 3 | |
Deferred income tax assets | |
$ | 9,066 | | |
$ | 6,249 | |
Less: Valuation allowance | |
| (5,463 | ) | |
| (5,715 | ) |
Deferred income tax assets net of valuation allowance | |
$ | 3,603 | | |
$ | 534 | |
| |
| | | |
| | |
Deferred income tax liabilities: | |
| | | |
| | |
Investments | |
$ | 3,282 | | |
$ | 369 | |
Deferred policy acquisition costs | |
| 321 | | |
| 165 | |
Deferred income tax liabilities | |
$ | 3,603 | | |
$ | 534 | |
| |
| | | |
| | |
Net deferred income tax asset (liability) | |
$ | – | | |
$ | – | |
As
of December 31, 2022, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately
$19.9 million, which will be available to offset future taxable income. Approximately $0.5 million expire on December 31, 2039, $0.2
million expire on December 31, 2040, and $1.6 million of the Company’s NOLs will expire on December 31, 2041. The remaining $17.6
million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $20.5 million of
capital loss carryforward that can only be used to offset capital gains and which will expire in December 2026 if not used prior.
As
of December 31, 2022, the Company had no unrecognized tax benefits. The Company analyzed its tax positions in accordance with the provisions
of Accounting Standards Codification Topic 740, Income Taxes, and has determined that there are currently no uncertain tax positions.
The Company generally recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.
The
Company files federal income tax returns as well as multiple state and local tax returns. The Company’s consolidated federal and
state income tax returns for years 2019 and forward are open for review by the Internal Revenue Service (“IRS”) and the various
state taxing authorities.
Note
7. Equity Incentive Plans
On
December 15, 2021, our shareholders approved the FG Financial Group, Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The
purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries
and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and
Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which
may be incentive stock options or nonqualified stock options), stock appreciation rights (or “SARs”), restricted shares,
restricted stock units (“RSUs”, and other share-based awards, and provides for a maximum of 1,500,000 shares available for
issuance.
As
of December 31, 2022, the Company had 256,382 RSUs outstanding, 25,000 restricted shares, and 130,000 non-qualified stock options outstanding
under its equity incentive plans.
RSUs
Outstanding
The
following table summarizes RSU activity for the years ended December 31, 2022 and 2021:
Schedule
of Restricted Stock Units Activity
Restricted Stock Units | |
Number of Units | | |
Weighted Average Grant Date Fair Value | |
Non-vested units, January 1, 2021 | |
| 148,486 | | |
$ | 5.44 | |
Granted | |
| 83,329 | | |
| 3.45 | |
Vested | |
| (67,160 | ) | |
| 5.64 | |
Forfeited | |
| – | | |
| – | |
Non-vested units, December 31, 2021 | |
| 164,655 | | |
$ | 4.35 | |
Granted | |
| 158,225 | | |
| 1.58 | |
Vested | |
| (66,498 | ) | |
| 4.63 | |
Forfeited | |
| – | | |
| – | |
Non-vested units, December 31, 2022 | |
| 256,382 | | |
$ | 2.57 | |
On
December 17, 2021, we issued a total of 83,329 RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning
with the first anniversary of the grant date, other than those RSUs granted to a former director. As the former director made himself
available to serve on the Board but was not elected to do so at the Company’s 2021 annual meeting of shareholders, the Board accelerated
the vesting of his RSUs, such that they all vested on January 1, 2022. This included 14,492 RSUs granted on December 17, 2021, as well
as an additional 15,224 RSUs previously granted.
On
August 19, 2022, we issued a total of 158,225 RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning
with the first anniversary of the grant date.
Restricted
Shares
On
July 31, 2022, the Company issued 25,000 restricted shares under the 2021 Equity Incentive Plan to an employee of the Company. The restriction
will be lifted on the first anniversary of the grant date.
Stock
Options Outstanding
On
January 12, 2021, in connection with Larry G. Swets, Jr.’s appointment as Chief Executive Officer, the Company entered into a Stock
Option Agreement (the “Stock Option”) with Mr. Swets. The Stock Option entitles Mr. Swets to purchase up to 130,000 shares
of the Company’s common stock at an exercise price of $3.38 per share. The Stock Option becomes vested and fully exercisable in
20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through
each applicable vesting date and that the Company’s book value per share shall have increased by 15% or more as compared to the
Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.
The
Stock Option contains performance and service conditions that affect vesting. Pursuant to ASC Topic 718- Stock Compensation, these
conditions have not been reflected in estimating the fair value of the award upon its grant date; however, the Company employed a Monte-Carlo
model to estimate the likelihood of satisfaction of the required performance and service conditions. This resulted in a derived service
period of approximately 3.3 years under the grant.
In
estimating the fair value of the Stock Option, the Company estimated volatility based on the historical volatility of our stock. The
risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the Stock Option. The
expected life of the Stock Option is assumed to be equivalent to its contractual term. The dividend rate is based on our historical rate,
which the Company anticipates will remain at zero. The following assumptions were used to determine the estimated fair value of the Stock
Option:
Schedule
of Fair Value of Stock Options
Expected volatility | |
| 45.60 | % |
Expected life (years) | |
| 10.00 | |
Risk-free interest rate | |
| 1.15 | % |
Dividend yield | |
| 0.00 | % |
The
following table summarizes activity for stock options issued for the years ended December 31, 2022 and 2021:
Schedule
of Stock Option Activity
Common Stock Options | |
Shares | | |
Weighted Ave Exercise Price | | |
Weighted Ave Remaining Contractual Term (yrs) | | |
Weighted Ave Grant Date Fair Value | | |
Aggregate Intrinsic Value | |
Outstanding, January 1, 2022 | |
| 130,000 | | |
$ | 3.38 | | |
| 9.04 | | |
$ | 1.88 | | |
$ | 49,400 | |
Exercisable, January 1, 2022 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
$ | – | |
Granted | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Exercised | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Cancelled | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Outstanding, December 31, 2022 | |
| 130,000 | | |
$ | 3.38 | | |
| 8.04 | | |
$ | 1.88 | | |
$ | – | |
Exercisable, December 31, 2022 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
$ | – | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Outstanding, January 1, 2021 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
$ | – | |
Exercisable, January 1, 2021 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
$ | – | |
Granted | |
| 130,000 | | |
| 3.38 | | |
| 10.00 | | |
| 1.88 | | |
| – | |
Exercised | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Cancelled | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Outstanding, December 31, 2021 | |
| 130,000 | | |
$ | 3.38 | | |
| 9.04 | | |
$ | 1.88 | | |
$ | 49,400 | |
Exercisable, December 31, 2021 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
$ | – | |
On
January 18, 2021, Company entered into an Equity Award Letter Agreement (the “Letter Agreement”) with Mr. Swets, pursuant
to which the Company clarified its intention to grant an additional 370,000 stock options, restricted shares or restricted stock units
pursuant to a future award (the “Future Award”), subject to the approval of an amended and/or new equity plan, among other
conditions. Specifically, under the Letter Agreement, no such Future Award may be granted until there is a determination by the Compensation
Committee of the specific vesting and other terms of the award, and an amended and/or new equity plan, in a form to be prepared and reviewed
by the Board of Directors of the Company (the “Board”), has been approved by the Board and Company stockholders that authorizes
a sufficient number of shares of common stock to make such Future Award.
Total
stock-based compensation expense for the years ended December 31, 2022 and 2021 was approximately $255,000 and $559,000, respectively.
As of December 31, 2022, total unrecognized stock compensation expense of $644,000 remains, which will be recognized through December
31, 2026. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative
expense.
Warrants
No
warrants were granted or exercised during the twelve months ended December 31, 2022 and 2021. On February 24, 2022, 1,500,000 warrants
with an exercise price of $15.00 expired. As of December 31, 2022, the Company did not have any warrants outstanding.
Note
8. Shareholders’ Equity
8.00%
Cumulative Preferred Stock, Series A
On
May 21, 2021, we completed the underwritten public offering of an additional 194,580 shares of our preferred stock designated as, 8.00%
Cumulative Preferred Stock, Series A, par value $25.00 per share (the “Series A Preferred Stock”), for net proceeds of approximately
$4.2 million, after deducting underwriting commissions and offering expenses. This included the exercise in full by the underwriters
of their over-allotment option to purchase up to an additional 25,380 shares.
As
of both December 31, 2022, and December 31, 2021, the Company had 894,580 of Series A Preferred Stock shares outstanding.
Dividends
on the Series A Preferred Stock are cumulative from the date of original issue and are payable quarterly on the 15th day of March, June,
September and December of each year, when, as and if declared by our Board of Directors or a duly authorized committee thereof. Dividends
are payable out of amounts legally available therefor at a rate equal to 8.00% per annum per $25.00 of stated liquidation preference
per share, or $2.00 per share of Series A Preferred Stock per year. Our Board of Directors declared the first quarter 2023 dividend on
the shares of Series A Preferred Stock on February 1, 2023. The Series A Preferred Stock
shares trade on the Nasdaq Stock Market under the symbol “FGFPP”.
Common
Stock
In
the fourth quarter of 2021, we sold a total of 750,000 shares of our common stock, at a price of $4.00 per share, for net proceeds of
approximately $2.5 million. Also in the fourth quarter, the Company completed a rights offering to holders of its common stock. Pursuant
to the rights offering, 691,735 shares were subscribed for, for net proceeds of approximately $2.7
million. The Company intends to use the net proceeds from the issuance of its common shares for working capital and other general
corporate purposes.
In
June 2022, we sold a total of 2,750,000 shares of our common stock in an underwritten public offering, at a price of $1.58 per share,
for net proceeds of approximately $3.8 million. On August 2, 2022, ThinkEquity, the underwriter with respect to the public offering,
partially exercised its overallotment option and we sold an additional 71,770 shares of our common stock, at a price of $1.58 per share,
for net proceeds of $0.1 million. The Company intends to use the net proceeds from the underwritten public offering for working capital
and other general corporate purposes.
On
November 3, 2022, the Company entered into a Sales Agreement with ThinkEquity LLC, pursuant to which the Company may offer and sell,
from time to time through ThinkEquity LLC, shares of the Company’s common stock, having an aggregate offering price of up to $2,575,976,
subject to the terms and conditions of the Sales Agreement. The Company filed a prospectus supplement to its registration statement on
Form S-3. Under the Sales Agreement, the ThinkEquity LLC may sell the Shares in sales deemed to be an “at-the-market offering”
as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933. The Company is not obligated to make any sales of the shares
under the Sales Agreement. As of December 31, 2022, the Company had not yet sold any shares under this Sales Agreement.
Retirement
of Treasury Stock
On
August 19, 2021, the Board approved the retirement of all 1,281,511 common stock treasury shares owned by the Company.
Note
9. Related Party Transactions
Related
party transactions are carried out in the normal course of operations and are measured in part by the amount of consideration paid or
received, as established and agreed by the parties. Management believes that consideration paid for such services in each case approximates
fair value. Except where disclosed elsewhere in these consolidated financial statements, the following is a summary of related party
transactions.
Metrolina
The
Company had previously invested $4.0 million as a limited partner in Metrolina, which invested in real estate through a real estate investment
trust wholly owned by Metrolina. The general partner of Metrolina, FGI Metrolina GP, LLC, was managed, in part, by Mr. Cerminara, the
Chairman of the Board of Directors of the Company. Metrolina’s investment program was managed by FG Funds Management LLC, an affiliate
of FG, which, with its affiliate, is the largest stockholder of the Company. In the fourth quarter 2021, we received approximately $5.0
million in cash from Metrolina, representing our initial investment of $4.0 million plus approximately $1.0 million in distributed earnings.
As a result, our investment in Metrolina was fully liquidated as of December 31, 2021.
Joint
Venture Agreement
On
March 31, 2020, the Company entered into the Limited Liability Company Agreement with Fundamental Global Asset Management, LLC (“FGAM”),
a newly-formed joint venture owned 50% by each of the Company and FG. The purpose of FGAM is to sponsor, capitalize and provide strategic
advice to investment managers in connection with the launch and/or growth of their asset management business and the investment products
they sponsor (each, a “Sponsored Fund”).
FGAM
is governed by a Board of Managers consisting of four managers, two of which have been appointed by each Member. The Company has appointed
two of its independent directors to the Board of Managers of FGAM. Certain major actions, including any decision to sponsor a new investment
manager, require the prior consent of both Members.
FG
Special Situations Fund
As
of December 31, 2022, the Company had invested $12.1 million, net of redemptions at cost, as a limited partner in the Fund. The general
partner of the Fund, and the investment advisor of the Fund are ultimately controlled by Mr. Cerminara, the Chairman of the Company’s
Board of Directors. Portions of the Company’s investment into the Fund were used to sponsor the launch of SPACs affiliated with
certain of our officers and directors.
Mr.
Cerminara, our chairman, and Mr. Swets, our Chief Executive Officer and Director, are managers of the sponsor company of FG New America
Acquisition Corp (“FGNA”). Mr. Cerminara, Mr. Swets and Mr. Baqar, our Executive Vice President and Chief Financial Officer,
serve as managers of the sponsor companies of FG Merger and FG Acquisition. Until FGNA’s business combination with OppFi (NYSE:
OPFI), Mr. Swets was the Chief Executive Officer and a Director of FGNA, Mr. Cerminara was a Director of FGNA, and Mr. Baqar was the
Chief Financial Officer of FGNA. Until Aldel’s business combination with Hagerty, Mr. Swets served as Senior Advisor to Aldel,
Mr. Baqar served as Chief Financial Officer of Aldel, and Mr. Cerminara served as a Director of Aldel. Messrs. Cerminara, Swets, and
Baqar also hold financial interests in the SPACs and/or their sponsor companies. Mr. Swets serves as Chairman of FG Merger, while Messrs.
Baqar and Cerminara serve as Director and Senior Advisor of FG Merger, respectively. Mr. Swets serves as Chief Executive Officer and
Director of FG Acquisition. Mr. Baqar serves as Chief Financial Officer, Secretary and Director of FG Acquisition. Mr. Cerminara serves
as Chairman of FG Acquisition.
FG
Merchant Partners
FGMP
was formed to co-sponsor newly formed SPACs with their founders or partners, as well as other merchant banking initiatives. The Company
holds a limited partner interest in FGMP. Certain of our directors and officers also hold limited partner interests in FGMP. Mr. Swets
holds a limited partner interest through Itasca Financial LLC, an advisory and investment firm for which Mr. Swets is managing member.
Mr. Baqar also holds a limited partner interest through Sequoia Financial LLC, an advisory firm for which Mr. Baqar is managing member.
Mr. Cerminara also holds a limited partner interest through Fundamental Global, LLC, a holding company for which Mr. Cerminara is the
manager and one of the members.
FGMP
has invested in the founder shares and warrants of Aldel, FG Merger, FG Acquisition and FGC. Certain of our directors and officers are
affiliated with these SPACs and their sponsor companies as previously described.
FG
Communities
In
October of 2022, the Company directly invested $2.0 million into FGC. The Company also holds an interest through its ownership in FGMP.
FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated
by FGC. Mr. Cerminara is the President and a director of FGC.
Shared
Services Agreement
On
March 31, 2020, the Company entered into a Shared Services Agreement (the “Shared Services Agreement”) with Fundamental Global
Management, LLC (“FGM”), an affiliate of FG, pursuant to which FGM provides the Company with certain services related to
the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial and
operational performance, providing a management team to supplement the executive officers of the Company, and such other services consistent
with those customarily performed by executive officers and employees of a public company. In exchange for these services, the Company
pays FGM a fee of $456,000 per quarter (the “Shared Services Fee”), plus reimbursement of expenses incurred by FGM in connection
with the performance of the Services, subject to certain limitations approved by the Company’s Board of Directors or Compensation
Committee from time to time.
The
Shared Services Agreement has an initial term of three years, and thereafter renews automatically for successive one-year terms unless
terminated in accordance with its terms. The Shared Services Agreement may be terminated by FGM or by the Company, by a vote of the Company’s
independent directors, at the end of the initial or automatic renewal term upon 120 days’ notice, subject to payment by the Company
of certain costs incurred by FGM to wind down the provision of services and, in the case of a termination by the Company without cause,
payment of a termination fee equal to the Shared Services Fee paid for the two quarters preceding termination.
In
the third quarter of 2022, the Shared Services Agreement was amended to eliminate termination fees and to increase the termination notice
from 120 days to 365 days. The Company paid $1,825,000 to FGM under the Shared Services Agreement for each of the twelve months ended
December 31, 2022 and 2021, respectively.
Note
10. Net Earnings Per Share
Net
earnings per share is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding
during the periods presented. In calculating diluted earnings per share, those potential common shares that are found to be anti-dilutive
are excluded from the calculation. The table below provides a summary of the calculations used in determining basic and diluted earnings
per share for the years ended December 31, 2022 and 2021.
Schedule of Numerators and Denominators Used in Calculation of Basic and Diluted Earnings Per Share
| |
2022 | | |
2021 | |
($ in thousands) | |
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Basic and diluted: | |
| | | |
| | |
Net income (loss) from continuing operations | |
$ | 1,088 | | |
$ | (7,333 | ) |
Income attributable to noncontrolling interest | |
| – | | |
| (1,326 | ) |
Dividends declared on Series A Preferred Shares | |
| (1,789 | ) | |
| (1,692 | ) |
Loss attributable to FG Financial Group, Inc. common shareholders from continuing operations | |
| (701 | ) | |
| (10,351 | ) |
Weighted average common shares | |
| 8,030,106 | | |
| 5,212,772 | |
Loss per common share from continuing operations | |
$ | (0.09 | ) | |
$ | (1.99 | ) |
| |
| | | |
| | |
Gain from sale of former insurance business | |
$ | – | | |
$ | (145 | ) |
Weighted average common shares outstanding | |
| 8,030,106 | | |
| 5,212,772 | |
| |
| | | |
| | |
Loss per share attributable to common shareholders | |
$ | (0.09 | ) | |
$ | (1.96 | ) |
The
following potentially dilutive securities outstanding as of December 31, 2022 and 2021 have been excluded from the computation of diluted
weighted-average shares outstanding as their effect would be anti-dilutive.
Schedule of Potentially Dilutive Securities Excluded from Calculation
| |
As of December 31, | |
| |
2022 | | |
2021 | |
Warrants to purchase common stock | |
| - | | |
| 1,500,000 | |
Options to purchase common stock | |
| 130,000 | | |
| 130,000 | |
Restricted shares | |
| 25,000 | | |
| - | |
Restricted stock units | |
| 256,382 | | |
| 164,655 | |
| |
| 411,382 | | |
| 1,794,655 | |
Note
11. Retirement plans
The
FG Financial Group, Inc. 401(k) Plan (the “Retirement Plan”) was established effective January 1, 2015, as a defined contribution
plan. The Retirement Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (“ERISA”);
eligible employees of the Company and its subsidiaries may participate in the plan. Employees who have completed one month of service
are eligible to participate and are permitted to make annual pre and post-tax salary reduction contributions not to exceed the limits
imposed by the Internal Revenue Code of 1986, as amended. Contributions are invested at the direction of the employee participant in
various money market and mutual funds. The Company matches 100% of each participant’s initial contributions up to 3% of a participant’s
eligible earnings and 50% of each participant’s contributions up to an additional 2% of a participant’s eligible earnings.
The Company may also elect to make a profit-sharing contribution to the Retirement Plan based upon discretionary amounts and percentages
authorized by the Company’s Board of Directors. For the years ended December 31, 2022 and 2021, the Company made matching contributions
to the Retirement Plan in the amounts of approximately $44,000 and $42,000, respectively, but did not make any profit-sharing contributions
to the Retirement Plan in either year.
Note
12. Commitments and Contingencies
Legal
Proceedings:
As
of December 31, 2022, the Company was not a party to any legal proceedings and was not aware of
any material claims or actions pending or threatened against us. From time to time, we are involved in legal proceedings and litigation
arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development
of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional
liabilities may arise for amounts in excess of the Company’s current reserves.
Operating
Lease Commitments:
In
July 2021, the Company entered into a lease agreement for office space in St. Petersburg, FL. The lease had a term of 12 months and was
not renewed upon expiration. Total minimum rent over the 12-month term was approximately $17,000. Due to the short-term nature of the
lease, the Company recognized lease expense on a straight-line basis over the term of the lease, with any variable lease payments recognized
in the period in which the obligation for the payment occurred. Rent expense related to the St. Petersburg office was approximately $10,000
for the twelve months ended December 31, 2022.
In
April 2022, the Company entered into a lease agreement for office space in Itasca, IL. The lease has a term of 44 months beginning on
May 1, 2022. Total minimum rent over the term of the lease is expected to be approximately $77,000. The Company has accounted for the
lease under ASC 842, Leases. The annual discount rate used for the Itasca office was 8%. As of December 31, 2022, the right of
use asset and lease liability are approximately $56,000, each, and held in “Other assets” and “Other liabilities”
on the balance sheet, respectively. Rent expense related to the Itasca office was approximately $17,000 for the twelve months ended December
31, 2022. Future minimum lease commitments are as follows:
Schedule of Future Minimum Lease Commitment
Year
ending December 31, | |
Minimum Commitment | |
2023 | |
$ | 21,000 | |
2024 | |
| 21,000 | |
2025 | |
| 21,000 | |
Imputed interest | |
| (7,000 | ) |
Total lease liability | |
$ | 56,000 | |
Total
rent expense included in general and administrative expenses on the Company’s Statements of Operations was approximately $27,000
and $19,000 for the years ended December 31, 2022, and 2021, respectively.
Note
13. Segment Reporting
The
Company has two operating segments—insurance and asset management. The chief operating decision maker (“CODM”) is the
Company’s Chief Executive Officer. The measure of profit or loss used by the CODM to identify and measure the Company’s reportable
segments is income before income tax. Our insurance segment consists of the operations of our Cayman Islands-based reinsurance subsidiary,
FGRe, which, as of December 31, 2022, included our seven reinsurance agreements, as well as the returns associated with the investments
made by our reinsurance operations, which, up until the sale of its final shares held in October 2022, included the Company’s FedNat
common stock investment, as well as a portion of our investments in the SPACs which we have sponsored. Net premiums earned within this segment relates entirely to property and
casualty assumed premium. Our asset management segment includes
our investment in the Fund, as well as our investment advisory agreement with FedNat.
The
following table presents the financial information for each segment that is specifically identifiable or based on allocations using internal
methodology as of and for the twelve months ended December 31, 2022 and 2021. The ‘other’ category in the table below consists
largely of corporate general and administrative expenses which have not been allocated to a specific segment. Segment assets for the
“other” category primarily consist of unrestricted cash in the amounts of $3.0 million and $14.2 million as of December 31,
2022 and 2021, respectively.
(in thousands)
Summary of Segment Reporting
For the year ended December 31, 2022 | |
Insurance | | |
Asset Management | | |
Other | | |
Total | |
Net premiums earned | |
$ | 12,998 | | |
$ | – | | |
$ | – | | |
$ | 12,998 | |
Net investment income | |
| 3,160 | | |
| 3,617 | | |
| – | | |
| 6,777 | |
Other income | |
| – | | |
| 195 | | |
| 125 | | |
| 320 | |
Total revenue | |
| 16,158 | | |
| 3,812 | | |
| 125 | | |
| 20,095 | |
Income (loss) before income tax | |
| | |
| | |
| ) | |
| |
| |
| | | |
| | | |
| | | |
| | |
As of December 31, 2022 | |
| | | |
| | | |
| | | |
| | |
Segment assets | |
$ | 27,086 | | |
$ | 19,070 | | |
$ | 3,319 | | |
$ | 49,475 | |
| |
| | | |
| | | |
| | | |
| | |
For the year ended December 31, 2021 | |
| | | |
| | | |
| | | |
| | |
Net premiums earned | |
$ | 4,864 | | |
$ | - | | |
$ | – | | |
$ | 4,864 | |
Net investment (loss) income | |
| (2,535 | ) | |
| 5,080 | | |
| - | | |
| 2,545 | |
Other income | |
| - | | |
| 186 | | |
| - | | |
| 186 | |
Total revenue | |
| 2,329 | | |
| 5,266 | | |
| - | | |
| 7,595 | |
Income (loss) before income tax | |
| ) | |
| | |
| ) | |
| ) |
| |
| | | |
| | | |
| | | |
| | |
As of December 31, 2021 | |
| | | |
| | | |
| | | |
| | |
Segment assets | |
$ | 14,657 | | |
$ | 11,413 | | |
$ | 14,759 | | |
$ | 40,829 | |
Note
14. Subsequent Events
Effective
February 17, 2023, the Company’s compensation committee approved a total of 415,000 restricted stock units to be granted to various
members of the Company’s management, subject to vesting terms.
FG
FINANCIAL GROUP, INC.